INTECH Investment Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.73M Buy
123,154
+102,527
+497% +$1.38M 0.02% 768
2025
Q4
$232K Sell
20,627
-5,672
-22% -$64.9K ﹤0.01% 1899
2025
Q3
$304K Hold
26,299
﹤0.01% 1815
2025
Q2
$322K Sell
26,299
-97,762
-79% -$1.23M ﹤0.01% 1830
2025
Q1
$1.78M Buy
124,061
+75,279
+154% +$1.18M 0.02% 829
2024
Q4
$777K Buy
48,782
+40,186
+467% +$795K 0.01% 1305
2024
Q3
$207K Buy
+8,596
New +$196K ﹤0.01% 1703

Other funds holding AVNS

INTECH Investment Management's AVNS Position: Q1 2026 in Review

INTECH Investment Management increased its Avanos Medical (AVNS) stake by 497% in Q1 2026, buying an estimated $1.38M and bringing the position to 123,154 shares worth $1.73M. The position accounts for 0.02% of the portfolio, ranked #768.

INTECH Investment Management first reported a position in AVNS in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.78M in Q1 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • INTECH Investment Management held 123,154 shares of Avanos Medical worth $1.73M as of Q1 2026.
  • INTECH Investment Management bought 102,527 Avanos Medical shares in Q1 2026, an estimated $1.38M.
  • Avanos Medical made up 0.02% of INTECH Investment Management's portfolio in Q1 2026, its #768 holding.
  • INTECH Investment Management first reported a position in Avanos Medical in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Avanos Medical position peaked at $1.78M in Q1 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.